SAMANTHA CARLSON: Open Payments
NPI 1043595960 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 32 payments from 12 companies in 2025. Trend: 2023 $423 · 2024 $412 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $138 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Amgen Inc. | 3 | $49 |
| Exact Sciences Corporation | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Novo Nordisk Inc | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| PFIZER INC. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: VRAYLAR, REXULTI, TRINTELLIX, OTEZLA, Cologuard Collection Kit, CAPLYTA, UBRELVY, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
